Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Analysis to Characterize the Real World Use Patterns, Efficacy and Safety of Ceftazidime-avibactam in the Management of Gram Negative Infections.

NCT04628572 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04628572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04628572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Analysis to Characterize the Real World Use Patterns, Efficacy and Safety of Ceftazidime-avibactam in the Management of Gram Negative Infections.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 29, 2021
Completion date
March 11, 2022
Enrollment
189 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

gram negative infections